BRWA
ARIA

B. Riley Wealth Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

B. Riley Wealth Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-700
Closed -$4.46K – 2300
2014
Q2 		$4.46K Buy
+700
New +$4.81K ﹤0.01% 2077
2013
Q4 		– Sell
-5,000
Closed -$92K – 740
2013
Q3 		$92K Hold
5,000
– – 0.03% 567
2013
Q2 		$87K Buy
+5,000
New +$88.6K 0.03% 587

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

B. Riley Wealth Advisors's ARIA Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2014, closing a stake of 700 shares — an estimated $4.46K sold.

B. Riley Wealth Advisors first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $92K in Q3 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 700 Ariad Pharmaceuticals Inc shares in Q3 2014, an estimated $4.46K.
  • B. Riley Wealth Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • B. Riley Wealth Advisors's Ariad Pharmaceuticals Inc position peaked at $92K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.